serum institute of india

Serum Institute's CEO Adar Poonawalla had asked if the India government would have Rs 80,000 crore for the distribution of the coronavirus vaccine.
Drugs Controller General of India issued a show cause notice to Serum institute of India after the Oxford cCovid-19 vaccine trial was halted.
It plans to begin trials by end of August.